Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Diabetes news topic | Vintage Vibes

Our eyes age too: Here’s how to reduce the risks of four common eye conditions

As an optometrist, I see how aging affects my patients every day. Their eyes are no exception. Losing their vision, and consequently, their independence, is one of the greatest fears older people have. Those who lose their vision are severely affected by it psychologically.

The Conversation

Ed Gamble on extreme body transformations: ‘Your life is horrible’

WELL ENOUGH: The comedian is perhaps best known for a podcast all about the joy of food – but his own health journey has been far from simple, Ed Gamble tells Emilie Lavinia on the Well Enough podcast

The Independent UK

GLP-1 Drugs Like Ozempic Are Showing a 47 Percent Reduction in Breast Cancer Risk in a Major New Study — and Weight Loss May Not Explain It

A study presented at ASCO 2026 and published June 10, 2026 found that GLP-1 receptor agonists (semaglutide, tirzepatide) are associated with a 30–47% reduction in breast cancer risk among women with diabetes or obesity. The effect may operate through mechanisms beyond weight loss. Here is the full analysis.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Rethinking Insulin at Its Core: Hua Tu on How Stability Innovation Is Shaping the Next Generation of Diabetes Care

Every individual living with type 1 diabetes understands the discipline the condition demands. Even minor deviations can result in significant fluctuations in glucose levels.

International Business Times

Women report poor sleep despite a good night’s rest — while men overestimate their own sleep quality

Disturbed sleep is a common problem — and one that has many serious consequences beyond feeling tired the next day. Research has linked insomnia and poor sleep to early mortality and diseases including diabetes and cardiovascular disease.

The Conversation

More sleep means good health? Answer is... Study says people with diabetes face risk of developing deadly liver disease with rise in nap time

More sleep means good health? Answer is no. Study says people with diabetes face risk of developing deadly liver disease with rise in nap time. Research presented at ENDO 2026 found that people with type 2 diabetes who take naps longer than 30 minutes may face a higher risk of…

The Economic Times

"American Diabetes Association Ejects Researchers from Conference for Sharing Editorial from Its Own Journal"

Aaron Terr (FIRE) reports, based on accounts from various publications. Some excerpts: The incident occurred outside a conference hall where… The post "American Diabetes Association Ejects Researchers from Conference for Sharing Editorial from Its Own Journal" appeared first on Reason.com.

Reason

Read news from The Economist, FT, and more,
with one subscription

DHS Says He's a Terrorist. His Lawyers Say He's Being Punished for Palestinian Advocacy.

The legal team of Salah Sarsour alleges that he risks death from being denied basic diabetes care after two months in detention.

Reason

Century-old tuberculosis vaccine could help treat diabetes, trials hint. How?

Repeated doses of a tuberculosis vaccine lowered insulin needs in patients with two forms of diabetes, new trial data show. But more research is needed to prove the benefit.

LiveScience

Scientists Unveil a Diabetes and Obesity Pill That Burns Fat Through Muscle — Without Killing Your Appetite or Causing Muscle Loss

Karolinska/Stockholm University published a new obesity-diabetes pill in Cell (June 2026) that activates muscle metabolism to burn fat and lower blood sugar without appetite suppression or muscle loss. Safe in early human trial.

Medical Daily

Ed Gamble on diabetes, body image and letting go of perfection

This week, comedian, presenter and Off Menu co-host Ed Gamble joins us for a candid conversation about living with Type 1 diabetes, navigating body image, and learning to let go of the pressure to do health perfectly.

The Independent UK

Finerenone Kidney Drug Shown to Protect Heart and Kidneys in Millions More Patients After Three Major 2026 Studies

Three major studies published in NEJM, JAMA, and The Lancet in June 2026 show finerenone protects kidneys and hearts in non-diabetic CKD patients, expanding its potential reach to millions.

Medical Daily

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

The Independent UK

What is PMOS (formerly PCOS)? What to know about the hormonal syndrome

Learn about the hormonal disorder polyendocrine metabolic ovarian syndrome (PMOS), formerly called polycystic ovary syndrome (PCOS).

LiveScience

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Breakthrough Drug Finerenone Now Proven to Protect the Kidneys and Heart in Millions More Patients Than Doctors Thought — Houston's CKD Patients Stand to Benefit Most

Major June 2026 studies show finerenone slows kidney disease and cuts heart failure risk even in patients without diabetes — expanding its benefit to millions. Houston has one of the highest CKD rates in Texas.

AAP

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today announced an IVF+ partnership with the Fertility Institute of Hawaii, bringing its advanced carrier screening and embryo analysis to Hawaii's largest IVF practice.Through the collaboration, patients will gain deeper genetic insight into their embryos during IVF, including risks tied…

MyLifeXP

5 Warning Signs Your Nerves May Be Dying

What if your body was quietly warning you about a serious health problem but you didn't recognize the signs? Many people dismiss occasional tingling, muscle weakness, or unexplained pain as stress, fatigue, or simply getting older. But in some cases, these seemingly harmless symptoms may be early warning signs of…

Medical Daily

A Quiet Breakthrough at ADA 2026: New Therapy Could Fill Gap for Patients Who Can't Use GLP-1 Drugs

Petrelintide emerged as a major ADA 2026 breakthrough, offering hope for patients who stop GLP-1 therapies due to nausea and GI side effects.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Attorneys urge release of mosque leader, saying he's been denied diabetes care in ICE custody

Attorneys for the president of Wisconsin's largest mosque say he is being denied basic medical care for diabetes and has lost 30 pounds since he was taken into custody two months ago by U.S. Immigration and Customs Enforcement

The Economic Times

US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients ‌with obesity, ⁠at the ⁠American Diabetes Association meeting in New Orleans.

MyLifeXP

Why You're Always Exhausted Even After a Full Night's Sleep

You go to bed on time, sleep for seven to nine hours, and expect to wake up feeling refreshed. Instead, you drag yourself out of bed, reach for another cup of coffee, and spend the day feeling drained. If this sounds familiar, you're not alone. Many people experience constant tiredness…

Medical Daily

Stanford Study Identifies Why Ozempic and Wegovy Don't Work in About 1 in 10 Patients

A Stanford Medicine study identifies a genetic variant in about 10% of people that may reduce response to GLP-1 drugs like Ozempic and Wegovy, offering new insight into why these widely used diabetes and weight-loss treatments fail for some patients and highlighting the future of precision medicine in Type 2…

The Guardian - UK

Triple-action diabetes jab shown to reduce blood sugar and body weight

Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugs

The Economic Times

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoarthritis pain in adults with obesity. Patients also experienced substantial weight loss. These findings were shared at an American Diabetes Association conference. Retatrutide targets multiple hormones related to obesity and…

Medical Daily

In 26 Days, Hundreds of Thousands of LA County Residents Will Lose Medi-Cal Dental Coverage — And Most Don't Know It's Happening

Hundreds of thousands of Los Angeles Medi-Cal beneficiaries could lose dental coverage on July 1, 2026, raising concerns about worsening diabetes, oral health complications, and reduced access to preventive care.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Immigration and Customs Enforcement

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.